Ipca Laboratories Ltd. — Regulatory Filings 2021

Oct 20, 2021

THRU ONLINE FILING

October 20, 2021

BSE Ltd. Phiroze Jeejeebhoy Towers Dalai Street Mumbai 400 023 Scrip Code - 524494

National Stock Exchange India Limited, Exchange Plaza, C-1, Block-G, Bandra Kurla Complex, Bandra -(East). Mumbai-400051. Scrip Code: IPCALAB

Dear Sirs,

Pursuant to Regulation 29 read with Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the Company will be held on Saturday, 13 November, 2021, inter-alia,

• 1. To consider and take on record the Standalone and Consolidated Unaudited Financial Results for the 2nd quarter and half year ended 30th September, 2021.
• 1. To consider declaration of Interim Dividend for the financial year 2021-22.
• 1. To consider sub-division of every 1 (one) equity share of the nominal/face value of Rs. 21- each into 2 (Two) equity shares of the nominal/face value of Re. 1/- each.
• 1. To consider holding of Extraordinary General Meeting of the members of the Company to approve the sub-division of the face value of equity shares as above and amendment to the Capital Clause of the Memorandum of Association of the Company.

We further wish to inform you that the Company has decided to fix 23rd November, 2021 as the 'Record Date' for the Members entitlement of interim dividend for the financial year 2021-22 that may be declared at the said Board Meeting on 13 November, 202.1.

Further with reference to the above meeting of the Board of Directors, we have already informed vide our letter dated 30,h September, 2021 that the trading window for dealing in the securities of the Company by the Insiders as defined under the SEBI (Prohibition of Insider Trading) Regulations, 2015 shall remain closed with immediate effect and^ until 48 hours after the declaration of the Company's unaudited financial results for the 2n quarter and half year ended 30,h September, 2021 of the financial year 2021-22, i.e., till 15 November, 2021.

Thanking you

Yours faithfully For Ipca Laboratories Limited

Harish P. Kamath (ACS 6792) Corporate Counsel & Company Secretary

Ipca Laboratories Ltd. www.ipca.com

125, Kandivli Industrial Estate,CIS No. 328, Kandivli (West), Mumbai400067 (Maharashtra), India | T:+91 22 62105000 F: +91 22 62105005 Regd. Office: 48, Kandivli Industrial Estate, Kandivli (West), Mumbai 400 067 (Maharashtra), India | T: +91 22 6647 4444 E: ipca@ipca.com CIN: L24239MH1949PLC007837